Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 1
1973 1
1975 6
1976 3
1977 5
1978 6
1979 14
1980 22
1981 20
1982 18
1983 10
1984 19
1985 11
1986 9
1987 7
1988 5
1989 4
1990 8
1991 9
1992 8
1993 3
1994 5
1995 11
1996 8
1997 14
1998 19
1999 14
2000 27
2001 30
2002 38
2003 35
2004 32
2005 55
2006 62
2007 65
2008 88
2009 68
2010 91
2011 92
2012 93
2013 115
2014 116
2015 102
2016 149
2017 143
2018 161
2019 199
2020 210
2021 276
2022 301
2023 279
2024 283
2025 91

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

467 results

Results by year

Filters applied: . Clear all
Page 1
Cannabis and Cannabinoids (PDQ): Health Professional Version.
PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. 2025 Feb 21. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2025 Feb 21. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389198 Free Books & Documents. Review.
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about the use of Cannabis and cannabinoids in the treatment of people with cancer. ...This summary is reviewed regularly and updated …
This PDQ cancer information summary for health professionals provides comprehensive, peer-reviewed, evidence-based information about …
Cannabis and Cannabinoids (PDQ): Patient Version.
PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. PDQ Integrative, Alternative, and Complementary Therapies Editorial Board. 2023 Aug 15. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. 2023 Aug 15. In: PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002–. PMID: 26389314 Free Books & Documents. Review.
This PDQ cancer information summary has current information about the use of Cannabis and cannabinoids in the treatment of people with cancer. ...It does not give formal guidelines or recommendations for making decisions about health care. Editorial Boards wr …
This PDQ cancer information summary has current information about the use of Cannabis and cannabinoids in the treatment of peo …
Gadolinium-HU-308-incorporated micelles.
Leung K. Leung K. 2011 Mar 15 [updated 2011 Apr 21]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2011 Mar 15 [updated 2011 Apr 21]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21542549 Free Books & Documents. Review.
There are two subtypes of cannabinoid receptors in mammalian tissues: CB1 and CB2 (1, 2). CB1 is expressed abundantly in neuronal terminals in the central nervous system (CNS) and in some peripheral tissues to inhibit neurotransmitter release. ...CB2 is also involved in in …
There are two subtypes of cannabinoid receptors in mammalian tissues: CB1 and CB2 (1, 2). CB1 is expressed abundantly in neuronal ter …
2,2,3,3-Tetramethylcyclopropanecarboxylic acid [3-(2-[11C]methoxyethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]amide.
Leung K. Leung K. 2010 Dec 6 [updated 2011 Jan 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 Dec 6 [updated 2011 Jan 27]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 21290620 Free Books & Documents. Review.
There are two subtypes of cannabinoid receptors in mammalian tissues: CB1 and CB2 (1, 2). CB1 receptors are expressed abundantly in neuronal terminals in the central nervous system (CNS) and in some peripheral tissues to inhibit neurotransmitter release. ...CB2 receptors a …
There are two subtypes of cannabinoid receptors in mammalian tissues: CB1 and CB2 (1, 2). CB1 receptors are expressed abundantly in n …
Phantom breast syndrome.
Ramesh, Shukla NK, Bhatnagar S. Ramesh, et al. Indian J Palliat Care. 2009 Jul;15(2):103-7. doi: 10.4103/0973-1075.58453. Indian J Palliat Care. 2009. PMID: 20668586 Free PMC article.
In this context, chronic pain following treatment for breast cancer surgery is a significantly under-recognized and under-treated problem. Various types of chronic neuropathic pain may arise following breast cancer surgery due to surgical trauma. ...There are a numb …
In this context, chronic pain following treatment for breast cancer surgery is a significantly under-recognized and under-treated pro …
N-[(1s)-1-[4-[[4-methoxy-2-[(4-[11C]methoxyphenyl)sulfonyl]-phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide.
Chopra A. Chopra A. 2010 May 12 [updated 2010 Jun 3]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2010 May 12 [updated 2010 Jun 3]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20642014 Free Books & Documents. Review.
There are two known sub-types of the G-protein-coupled cannabinoid receptors, CB1R and CB2R, and they are believed to participate in many physiological processes such as neurotransmission, energy homeostasis, and the control of immune cell function (1). ...A variety of CB2 …
There are two known sub-types of the G-protein-coupled cannabinoid receptors, CB1R and CB2R, and they are believed to participate in …
Latest advances in cannabinoid receptor agonists.
Thakur GA, Tichkule R, Bajaj S, Makriyannis A. Thakur GA, et al. Expert Opin Ther Pat. 2009 Dec;19(12):1647-73. doi: 10.1517/13543770903436505. Expert Opin Ther Pat. 2009. PMID: 19939187 Review.
BACKGROUND: Since the discovery of cannabinoid receptors and their endogenous ligands in early 1990s, the endocannabinoid system has been shown to play a vital role in several pathophysiological processes. It has been targeted for the treatment of several diseases includin …
BACKGROUND: Since the discovery of cannabinoid receptors and their endogenous ligands in early 1990s, the endocannabinoid system has …
Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1.
Ramer R, Merkord J, Rohde H, Hinz B. Ramer R, et al. Biochem Pharmacol. 2010 Apr 1;79(7):955-66. doi: 10.1016/j.bcp.2009.11.007. Epub 2009 Nov 13. Biochem Pharmacol. 2010. PMID: 19914218
Although cannabinoids exhibit a broad variety of anticarcinogenic effects, their potential use in cancer therapy is limited by their psychoactive effects. Here we evaluated the impact of cannabidiol, a plant-derived non-psychoactive cannabinoid, on cancer …
Although cannabinoids exhibit a broad variety of anticarcinogenic effects, their potential use in cancer therapy is limited by …
The cannabinoid R+ methanandamide induces IL-6 secretion by prostate cancer PC3 cells.
Olea-Herrero N, Vara D, Malagarie-Cazenave S, Díaz-Laviada I. Olea-Herrero N, et al. J Immunotoxicol. 2009 Dec;6(4):249-56. doi: 10.3109/15476910903241696. J Immunotoxicol. 2009. PMID: 19908944 Free article.
In the present study, we have investigated the effect of the cannabinoid R+ methanandamide (MET) in the androgen-resistant prostate cancer PC3 cells. ...Our findings also suggest that CB2 agonists may offer a novel approach in the treatment of prostate cancer …
In the present study, we have investigated the effect of the cannabinoid R+ methanandamide (MET) in the androgen-resistant prostate …
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.
Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Johnson JR, et al. J Pain Symptom Manage. 2010 Feb;39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008. Epub 2009 Nov 5. J Pain Symptom Manage. 2010. PMID: 19896326 Free article. Clinical Trial.
However, the results from the European Organisation for Research and Treatment of Cancer Quality of Life Cancer Questionnaire showed a worsening in nausea and vomiting with THC:CBD compared with placebo (P = 0.02), whereas THC had no difference (P = 1.0). ...This st …
However, the results from the European Organisation for Research and Treatment of Cancer Quality of Life Cancer Questionnaire …
467 results